IN2014DN10658A - - Google Patents

Download PDF

Info

Publication number
IN2014DN10658A
IN2014DN10658A IN10658DEN2014A IN2014DN10658A IN 2014DN10658 A IN2014DN10658 A IN 2014DN10658A IN 10658DEN2014 A IN10658DEN2014 A IN 10658DEN2014A IN 2014DN10658 A IN2014DN10658 A IN 2014DN10658A
Authority
IN
India
Prior art keywords
compound
formula
influenza
preparing
useful
Prior art date
Application number
Other languages
English (en)
Inventor
Mohammed Homman
Ngarita Kingi
Jan Bergman
Robert Berg
Original Assignee
Vironova Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=48444409&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IN2014DN10658(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Vironova Ab filed Critical Vironova Ab
Publication of IN2014DN10658A publication Critical patent/IN2014DN10658A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/041,2,3-Triazoles; Hydrogenated 1,2,3-triazoles
    • C07D249/061,2,3-Triazoles; Hydrogenated 1,2,3-triazoles with aryl radicals directly attached to ring atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/16Antivirals for RNA viruses for influenza or rhinoviruses
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C07D249/101,2,4-Triazoles; Hydrogenated 1,2,4-triazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D261/00Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/02Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
    • C07D261/06Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
    • C07D261/10Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D261/18Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Pulmonology (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
IN10658DEN2014 2012-05-18 2013-05-17 IN2014DN10658A (fr)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201261648700P 2012-05-18 2012-05-18
US201261659516P 2012-06-14 2012-06-14
US201261666286P 2012-06-29 2012-06-29
US201361774991P 2013-03-08 2013-03-08
PCT/EP2013/060266 WO2013171334A1 (fr) 2012-05-18 2013-05-17 Composés méthanethiones ayant une activité antivirale

Publications (1)

Publication Number Publication Date
IN2014DN10658A true IN2014DN10658A (fr) 2015-08-28

Family

ID=48444409

Family Applications (1)

Application Number Title Priority Date Filing Date
IN10658DEN2014 IN2014DN10658A (fr) 2012-05-18 2013-05-17

Country Status (21)

Country Link
US (1) US9359310B2 (fr)
EP (1) EP2870141B1 (fr)
JP (2) JP6484168B2 (fr)
KR (1) KR102092207B1 (fr)
CN (1) CN104540810B (fr)
AU (1) AU2013261735B2 (fr)
BR (1) BR112014028632B1 (fr)
CA (1) CA2879816C (fr)
CL (1) CL2014003116A1 (fr)
DK (1) DK2870141T3 (fr)
EA (1) EA029044B1 (fr)
ES (1) ES2657942T3 (fr)
HK (1) HK1210165A1 (fr)
IL (1) IL235742A0 (fr)
IN (1) IN2014DN10658A (fr)
MX (1) MX356846B (fr)
MY (1) MY169094A (fr)
NZ (1) NZ702073A (fr)
SG (1) SG11201407703QA (fr)
WO (1) WO2013171334A1 (fr)
ZA (1) ZA201409220B (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9359310B2 (en) * 2012-05-18 2016-06-07 Vironova Influenza Ab Methanethione compounds having antiviral activity
CN107056762B (zh) * 2016-12-22 2020-08-28 四川百利药业有限责任公司 一种用作抗流感病毒的双羰基类似物
WO2021204924A1 (fr) 2020-04-09 2021-10-14 Vironova Medical Ab Composés destinés à être utilisés dans le traitement de l'hypercytokinémie
WO2021204923A1 (fr) 2020-04-09 2021-10-14 Vironova Medical Ab Agents antiviraux

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6642390B2 (en) 2001-07-11 2003-11-04 Lexicon Pharmaceuticals, Inc. One step synthesis of 1,2,3-triazole carboxylic acids
AU2004218260A1 (en) * 2003-01-28 2004-09-16 Aventis Pharma S.A. N-aryl heteroaromatic products, compositions containing same and use thereof
US8207205B2 (en) 2008-04-21 2012-06-26 Institute For Oneworld Health Compounds, compositions and methods comprising oxadiazole derivatives
RU2012104214A (ru) * 2009-08-05 2013-09-10 Верситек Лимитед Противовирусные соединения и способы их получения и применения
EA201390476A1 (ru) 2010-09-28 2013-08-30 Бристол-Майерс Сквибб Компани Новые пиперазиновые аналоги с замещенными гетероарильными группами в качестве противовирусных средств широкого применения против гриппа
EP2484655A1 (fr) 2011-02-04 2012-08-08 Vironova AB Procédé de thionation et agent de thionation
US9359310B2 (en) * 2012-05-18 2016-06-07 Vironova Influenza Ab Methanethione compounds having antiviral activity
JP6762767B2 (ja) * 2016-06-01 2020-09-30 キヤノン株式会社 撮像素子、撮像装置、および撮像信号処理方法

Also Published As

Publication number Publication date
EA201401277A1 (ru) 2015-04-30
CL2014003116A1 (es) 2015-08-07
AU2013261735B2 (en) 2017-07-20
EP2870141A1 (fr) 2015-05-13
KR102092207B1 (ko) 2020-03-23
EA029044B1 (ru) 2018-02-28
MX356846B (es) 2018-06-18
US20150133468A1 (en) 2015-05-14
JP2018065817A (ja) 2018-04-26
BR112014028632B1 (pt) 2020-01-28
DK2870141T3 (da) 2018-01-29
NZ702073A (en) 2017-07-28
ES2657942T3 (es) 2018-03-07
MY169094A (en) 2019-02-18
KR20150012289A (ko) 2015-02-03
BR112014028632A8 (pt) 2018-04-03
MX2014014007A (es) 2015-05-11
JP2015517516A (ja) 2015-06-22
SG11201407703QA (en) 2015-01-29
US9359310B2 (en) 2016-06-07
HK1210165A1 (en) 2016-04-15
IL235742A0 (en) 2015-02-01
JP6484168B2 (ja) 2019-03-13
CN104540810B (zh) 2017-01-18
WO2013171334A1 (fr) 2013-11-21
CA2879816C (fr) 2020-07-07
BR112014028632A2 (pt) 2017-06-27
ZA201409220B (en) 2016-08-31
AU2013261735A1 (en) 2015-01-22
CN104540810A (zh) 2015-04-22
CA2879816A1 (fr) 2013-11-21
EP2870141B1 (fr) 2017-11-22

Similar Documents

Publication Publication Date Title
PH12016501375A1 (en) Pyridin-2-amides useful as cb2 agonists
PH12015502839B1 (en) Antiviral compounds
PH12015501843A1 (en) Novel pyrazol derivatives
PH12015501083B1 (en) Novel pyridine derivatives
PH12015500813A1 (en) Pyrrolotriazinone derivatives as pi3k inhibitors
UA114655C2 (uk) Піридин-2-аміди, придатні як агоністи канабіноїдного рецептора 2
MX2014012477A (es) Inhibidores pirrolopirazona de tanquirasa.
IN2014DN06104A (fr)
UA116239C2 (uk) Нові похідні піридину
MX2014002936A (es) Nuevos derivados de acido betulinico con actividad antiviral.
MX349373B (es) Nuevos derivados de pirazina.
MX2014010433A (es) Nueva forma cristalina de sulfato de sitagliptina.
UA111333C2 (uk) Спосіб одержання l-аргінінової солі периндроприлу
JO3063B1 (ar) مركب مبتكر وطرق لانتاجه
MY180006A (en) Azetidinyloxyphenylpyrrolidine compounds
GEP201706626B (en) Synthesis of (s)-nifuratel
GB201107985D0 (en) Process
IN2014DN10658A (fr)
IN2015DN00085A (fr)
MX2014008918A (es) Nuevos derivados de pirrolidina.
MX348841B (es) Derivados de pirimidooxazocina como inhibidores de mtor.
IN2013MU02279A (fr)
MX2016007130A (es) Nuevo procedimiento de sintesis del 7-metoxi-naftaleno-1-carbaldeh ido y aplicacion en la sintesis de la agomelatina.
UA106373C2 (ru) Применение поллентара как средства фригопротекторного действия